Regino Gonzalez-Peralta
Pediatric Gastroenterology · Orlando, FLNPI 1992752372
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Mirum Pharmaceuticals, Inc. at 35.7% of the total. Among pediatric gastroenterology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 273 payments — averaging $1042.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mirum Pharmaceuticals, Inc.$102K
- Ipsen Biopharmaceuticals, Inc$80K
- Albireo Pharma, Inc.$48K
- AstraZeneca$28K
- Orphalan Inc$11K
- Gilead$6K
- plus $10K from 11 others
Across 142 payments — averaging $2737.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mirum Pharmaceuticals, Inc.$116K
- Bristol Myers Squibb$88K
- Gilead$83K
- AbbVie$44K
- Merck$26K
- Albireo Pharma, Inc.$18K
- plus $14K from 2 others
What the payments were for
- Consulting fees$108,16938%
- Speaking & faculty fees$118,96642%
- Travel & lodging$49,38317%
- Food & beverage$8,1413%
- Education$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | 128 | $101,523 |
| Ipsen Biopharmaceuticals, Inc | 46 | $80,456 |
| Albireo Pharma, Inc. | 48 | $47,974 |
| AstraZeneca(2 entities) | 17 | $27,976 |
| Orphalan Inc | 10 | $10,818 |
| Gilead | 6 | $5,735 |
| Sarepta Therapeutics, Inc. | 1 | $5,110 |
| Boehringer Ingelheim International GmbH | 1 | $1,750 |
| Genentech, Inc. | 1 | $1,680 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,050 |
| Regeneron Healthcare Solutions, Inc. | 3 | $156 |
| Sanofi | 1 | $122 |
| AbbVie | 1 | $110 |
| Merck | 1 | $99 |
| Fresenius Kabi USA, LLC | 1 | $96 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Travere Therapeutics, Inc. | 6 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$284,689 in reported general payments places this provider in the 95th percentile of 128 pediatric gastroenterology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SyprineTrientine Hcl | 11 | $221,696 |
Paid to pharmacies, not to this prescriber.
Other pediatric gastroenterology in Orlando
- Yamen SmadiOrlando$593K
- Akash PandeyOrlando$99K
- Shaista SafderOrlando$80K
- Jeffrey BornsteinOrlando$35K
- Stefany Hernandez BenabeOrlando$26K
- Dellys SolerOrlando$18K
- Devendra MehtaOrlando$15K
- Justin de BoerOrlando$11K
- Samit PatelOrlando$7K
- Nishant PatelOrlando$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.